Page last updated: 2024-09-04

olmesartan and Anterior Choroidal Artery Infarction

olmesartan has been researched along with Anterior Choroidal Artery Infarction in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Araki, R; Hamamoto, T; Minami, C; Yamada, H1

Other Studies

1 other study(ies) available for olmesartan and Anterior Choroidal Artery Infarction

ArticleYear
[Orolingual Angioedema after Recombinant Tissue Plasminogen Activator Treatment in Acute Cardiogenic Cerebral Embolism Patient Using Olmesartan: A Case Report].
    Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan, 2022, Volume: 142, Issue:1

    Topics: Acute Disease; Aged, 80 and over; Angioedema; Angiotensin II Type 1 Receptor Blockers; Cerebral Infarction; Humans; Imidazoles; Intracranial Embolism; Male; Recombinant Proteins; Tetrazoles; Tissue Plasminogen Activator

2022